FDA 510(k) Content Requirements: Complete Submission Checklist

Quick answer

A complete FDA 510(k) premarket notification must satisfy 21 CFR 807.87 and the section structure in FDA's "Content of a Premarket Notification [510(k)] Submission" guidance. At minimum, your submission package needs a cover letter, CDRH cover sheet (Form FDA 3514), user fee documentation (Form FDA 3601 when applicable), truthful and accuracy certification, Indications for Use (Form FDA 3881), either a 510(k) summary or 510(k) statement, financial certification or disclosure under 21 CFR Part 54 when required, device description, substantial equivalence comparison to a predicate, proposed labeling (including instructions for use), and performance data appropriate to device type—including sterilization, biocompatibility, software, and bench/clinical testing as applicable. Before substantive review, FDA applies the Refuse to Accept (RTA) policy to screen for administrative completeness. Most submissions today are filed electronically through CDRH Portal using eSubmitter.

Who this applies to

This checklist applies to manufacturers and U.S. agents preparing a Traditional, Special, or Abbreviated 510(k) for Class I or Class II devices subject to premarket notification under section 510(k) of the Federal Food, Drug, and Cosmetic Act. It covers the content of the submission—not predicate selection strategy (see related predicate search workflow) or quality system inspection readiness.

Use this guide when you are assembling a submission dossier, preparing for RTA screening, or mapping internal design history file (DHF) sections to FDA's expected 510(k) structure.

Legal foundation: 21 CFR 807.87

21 CFR 807.87 lists the information FDA may require in a 510(k). Although FDA's guidance organizes content into numbered sections for reviewer convenience, the regulation remains the statutory basis. Key paragraphs include:

Failure to address applicable paragraphs is a common RTA finding. Map each regulatory element to a section in your table of contents before upload.

FDA "Content of a 510(k)" section map

FDA's guidance "Content of a Premarket Notification [510(k)] Submission" organizes expected content into sections I through XX (and beyond for device-specific data). The table below maps the core administrative and technical sections most 510(k)s require:

Not every section applies to every device. A non-sterile, non-powered manual instrument may omit sterilization and software sections but must still justify omissions in the cover letter or device-specific sections.

Step-by-step assembly workflow

Step 1 — Confirm submission type and pathway

Determine whether you are filing a Traditional, Special, or Abbreviated 510(k). Special and Abbreviated 510(k)s require additional elements (e.g., design control summary for Special; standards-based Abbreviated reports). State the pathway explicitly in Section I (Cover Letter).

Step 2 — Complete administrative forms

1. Form FDA 3514 (CDRH Premarket Review Submission Cover Sheet): Enter device trade name, common name, product code, regulation number, panel, and contact information.
2. Form FDA 3601 (User Fee Cover Sheet): Attach proof of MDUFA fee payment or document fee exemption (e.g., small business determination).
3. Verify establishment registration and device listing are current in FURLS before or concurrent with submission.

Step 3 — Draft the cover letter (Section I)

The cover letter is FDA's routing document. Include:

• Submitter name, address, and authorized representative
• 510(k) submission type (Traditional, Special, Abbreviated)
• Device name, model numbers, and product code
• Primary predicate 510(k) number(s) and device name
• Statement of substantial equivalence intent
• Reference to any Q-Sub (Pre-Submission) meeting minutes by number
• List of previous submissions for the same device (if any)
• Table of contents with hyperlinks (for eSubmitter) or page references
• Declaration of confidentiality requests for trade secret sections

Step 4 — Prepare Indications for Use (Form FDA 3881)

Form FDA 3881 captures the Indications for Use (IFU) statement—the single most important text FDA clears. Requirements:

• Use FDA's current Form 3881 template
• State prescription (Rx) vs over-the-counter (OTC) use
• Describe patient population, anatomical site, clinical condition, and environment of use
• Align IFU with the predicate unless differences are justified with data
• Ensure proposed labeling repeats the cleared IFU verbatim after clearance

Misalignment between Form 3881, labeling, and the predicate IFU is a frequent RTA and review finding.

Step 5 — Choose 510(k) summary vs 510(k) statement

Under 21 CFR 807.87(f), you must provide either:

The summary must be complete enough for a third party to understand SE without reading the full submission. If you submit a statement, follow 21 CFR 807.93 requirements.

Step 6 — Sign truthful and accuracy certification

21 CFR 807.87(e) requires a signed certification that:

• All data and information are truthful and accurate
• No material fact is omitted
• Any material false statement is subject to penalties

This 510(k) Certification must be signed by a person with authority to bind the submitter. Unsigned or undated certifications trigger RTA refusal.

Step 7 — Financial certification under 21 CFR Part 54

When your 510(k) includes clinical data, include either:

• Financial Certification (Form FDA 3654) — certifying no disqualified financial interests, or
• Financial Disclosure (Form FDA 3655) — listing financial interests of clinical investigators

Apply Part 54 when data from clinical investigations conducted under FDA regulations are included, or when you rely on published clinical studies tied to disqualified investigators. Bench testing alone typically does not trigger Part 54.

Step 8 — Build device description and SE comparison

Section XII (Device Description) should include:

• Device components, materials, and dimensions
• Principles of operation and energy source (if any)
• Variants, accessories, and sterile vs non-sterile configurations
• Photographs, engineering drawings, or exploded diagrams

Section XIII (Substantial Equivalence Discussion) must compare subject and predicate devices on:

• Intended use (Form 3881 vs predicate IFU)
• Technological characteristics (design, materials, energy, software, performance)
• Rationale for why differences do or do not raise new questions of safety and effectiveness
• Reference to performance testing that supports as safe and effective (ASSE)

Step 9 — Compile labeli...